News
Important Only
CMI Media Group unveils inaugural Media Vitals HCP Global research
LONDON, Feb. 18, 2025 /PRNewswire/ -- Healthcare agency CMI Media Group, a WPP company (NYSE: WPP), has unveiled its first ever Media Vitals(TM) HCP Global research. The new report provides insights into the media preferences of healthcare professionals (HCPs) on a global scale. Insights were gathe...PR Newswire
Tue, Feb 18
1 Top Cryptocurrency to Buy Before It Soars 1,453%, According to ARK Invest CEO Cathie Wood
Cathie Wood and her firm ARK Invest have a propensity for high-flying tech and artificial intelligence stocks. That's why it's no surprise to see Wood and ARK embracing cryptocurrencies and the blockchain networks they run on. In fact, few have been more optimistic about cryptocurrencies than Wood, ...The Motley Fool
Tue, Feb 18
BUZZ-H&E Equipment jumps after receiving takeover bid from Herc
** Shares of rental equipment co H&E Equipment Services HEES.O up 14% at $99.50 premarket** Co receives an about $3.83 bln buyout proposal from Herc Holdings HRI.N** Herc offers $104.59 per share in cash and stock; offer represents about 20% premium on H&E's last close on Friday** Last m...Reuters
Tue, Feb 18
China tech rally presses ahead as Xi's meeting spurs bets of policy shift
Repeats to widen distribution with no changes to headline and textBy Jiaxing Li HONG KONG, Feb 18 (Reuters) - Chinese tech stocks continued to rally on Tuesday on optimism that President Xi Jinping's rare meeting with the country's tech entrepreneurs foreshadowed a regulatory U-turn after...Reuters
Tue, Feb 18
BUZZ-ReShape Lifesciences slumps after $6 mln public offering
** Shares of metabolic health solutions firm ReShape Lifesciences RSLS.O fall 57.5% to $1 premarket** On Saturday, RSLS said it is raising $6 mln through a public offering of shares and warrants** Co selling ~2.6 mln units, each consisting of one share and one warrant, at $2.33 per unit** Warrants c...Reuters
Tue, Feb 18
BREAKINGVIEWS-Tank maker’s surge depends on political air cover
The author is a Reuters Breakingviews columnist. The opinions expressed are his own.By Liam Proud LONDON, Feb 18 (Reuters Breakingviews) - Will European governments muster the resources to defend themselves? That’s what investors in Rheinmetall RHMG.DE are betting. Shares in the $43 billion Germa...Reuters
Tue, Feb 18
BUZZ-Diamondback rises after $4.08 billion deal for Midland assets
** Shares of oil and natural gas company Diamondback Energy FANG.O rise 1.2% to $158.90 premarket** Co to buy certain units of Encap-backed energy producer Double Eagle in about $4.08 bln cash-and-stock deal** Co to pay $3 billion in cash and 6.9 million shares, and transaction is expected to close ...Reuters
Tue, Feb 18
Axsome Therapeutics Revenue Surges 66%
Biopharmaceutical firm Axsome Therapeutics (NASDAQ:AXSM) reported mixed fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 18. The company achieved substantial revenue growth, with sales hitting $118.8 million, surpassing analyst estimates of $118 million. However, its adjusted earnings per...The Motley Fool
Tue, Feb 18
The Trade Desk Stock Tumbles. Is AppLovin the Culprit?
Investors in The Trade Desk (NASDAQ: TTD) were seeing red on Thursday as the stock plunged, but they were also green with envy.As shares of The Trade Desk tumbled more than 30%, fellow adtech titan AppLovin (NASDAQ: APP) was soaring on its earnings report, jumping more than 20% on its fourth-quarter...The Motley Fool
Tue, Feb 18
BUZZ-Morgan Stanley downgrades Hims and Hers to 'equal weight' after recent share run
** Morgan Stanley downgrades rating on telehealth firm Hims and Hers HIMS.N to "equal weight" from "overweight"** HIMS shares down marginally at $60.35 premarket ** "While HIMS checks a lot of boxes we evaluate for an investment thesis ... meaningful outperformance in the stock ...Reuters
Tue, Feb 18
BUZZ-Teva rises as FDA accepts to review biosimilar to eye disease drug Eylea
** U.S.-listed shares of Israel-based drugmaker Teva Pharmaceutical Industries TEVA.TA, TEVA.N rises 6.6% to $17.32 premarket** TEVA and partner Biotech Alvotech ALVO.O say the U.S. FDA has accepted for review its marketing application for a biosimilar or close copy of Regeneron's REGN.O Eylea *...Reuters
Tue, Feb 18
Yiren Digital Integrates DeepSeek to Boost Innovation and Operational Excellence
BEIJING, Feb. 18, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China, has officially integrated with DeepSeek, marking a significant milestone ...PR Newswire
Tue, Feb 18
BUZZ-Bath & Body Works up after J.P.Morgan upgrades to 'overweight'
Updates** Shares of beauty and skincare firm Bath & Body Works BBWI.N rise ~4% to $37.98 premarket** Brokerage J.P.Morgan upgrades stock to "overweight" from "neutral" citing potential for revenue growth in FY25** Brokerage sees BBWI's "three-legged stool" of product ...Reuters
Tue, Feb 18
BUZZ-Entergy rises after Q4 profit beat
** Shares of U.S.-based utility company Entergy ETR.N rise 2% to $84.20 premarket** Co's Q4 profit comes ahead of estimates, helped by lower operating expenses and higher electricity demand** Reports Q4 adj. profit of 66 cents vs est. of 64 cents - data compiled by LSEG** Forecasts 2025 adj. ear...Reuters
Tue, Feb 18
Is Chevron an Undervalued Dividend Stock?
Chevron's (NYSE: CVX) business is booming, but the long-term viability remains the key.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »*Stock prices used were the afternoon prices of Feb. 13, 2025. The video was ...The Motley Fool
Tue, Feb 18
BUZZ-Fluor falls after downbeat annual profit forecast, Q4 results; announces CEO transition
** Shares of construction firm Fluor FLR.N down 6.7% at $40.50 premarket** Company forecasts annual adjusted EPS between $2.25 and $2.75, compared with Street estimates of $2.95 - data compiled by LSEG** Also reports Q4 revenue rise of 11.5% to $4.26 billion, below estimates of $4.42 billion, while ...Reuters
Tue, Feb 18
Investors Obsess Over This Metric for XRP, but Does It Actually Matter?
A widely watched coin like XRP (CRYPTO: XRP) is bound to be immersed in a constant discussion about every single one of its aspects and its relevant metrics.If you're thinking about investing in it, or if you're already holding it, you're doubtlessly exposed to this chatter. And whether you admit it...The Motley Fool
Tue, Feb 18
